The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): A phase II precision medicine trial (NCT02213289).
 
Smita Suhas Joshi
No Relationships to Disclose
 
Steven Brad Maron
No Relationships to Disclose
 
S Lomnicki
No Relationships to Disclose
 
Blase N. Polite
Consulting or Advisory Role - AstraZeneca; Pfizer
Speakers' Bureau - Bayer/Onyx
Research Funding - Merck
Other Relationship - Gerson Lehrman Group
 
Manish Sharma
Consulting or Advisory Role - Abbvie; Bayer; Ipsen; Taiho Pharmaceutical
 
Jennifer Ibe
No Relationships to Disclose
 
Kenisha Allen
No Relationships to Disclose
 
Christine Racette
No Relationships to Disclose
 
Murtuza M. Rampurwala
Stock and Other Ownership Interests - Glaxosmithkline
Honoraria - Medscape
Consulting or Advisory Role - Celgene
Travel, Accommodations, Expenses - Dava Oncology; Merck
 
Andrea Louise Amico
No Relationships to Disclose
 
Ardaman Shergill
No Relationships to Disclose
 
Mark Kozloff
Honoraria - Abbvie; Genentech/Roche
Consulting or Advisory Role - Abbvie; Genentech/Roche
Speakers' Bureau - Abbvie; Amgen; Genentech/Roche; Lilly; Merck
 
Brooke Elizabeth Phillips
No Relationships to Disclose
 
Grace K. Suh
No Relationships to Disclose
 
Sunil Narula
No Relationships to Disclose
 
Shayan Rayani
No Relationships to Disclose
 
Kristen Kipping-Johnson
No Relationships to Disclose
 
Erin Wojak
No Relationships to Disclose
 
Hedy L. Kindler
Consulting or Advisory Role - Aduro Biotech; AstraZeneca; Bayer; Celgene; Genentech/Roche; GlaxoSmithKline; MedImmune; Merck; Plexxikon; Verastem
Research Funding - AB Science; Aduro Biotech; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Incyte; Lilly; MedImmune; Merck; Verastem
Expert Testimony - Aduro Biotech
 
Daniel V.T. Catenacci
Honoraria - Amgen; Bristol-Myers Squibb; Five Prime Therapeutics; Foundation Medicine; Genentech/Roche; Genmab; Gritstone Bio; Guardant Health; Lilly; Merck; NantWorks; OncoPlex Diagnostics; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Genentech/Roche; OncoPlex Diagnostics
Speakers' Bureau - Foundation Medicine; Genentech/Roche; Guardant Health; Lilly; NantWorks
Research Funding - Genentech; OncoPlex Diagnostics